Ranolazine Implantable Cardioverter-Defibrillator Trial
NCT01215253
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
1012
Enrollment
OTHER
Sponsor class
Conditions
Ischemic Cardiomyopathy
Nonischemic Cardiomyopathy
Heart Failure
Interventions
DRUG:
Ranolazine
Sponsor
University of Rochester